Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 256-262

  Schmid, M P ^a   Franckena, M ^a,b   Kirchheiner, K ^a   Sturdza, A ^a   Georg, P ^a   Dorr W ^a   Potter R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Chemotherapy; Cisplatin; Distant metastasis; Prognostic factors; Radiotherapy

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CHEMORADIOTHERAPY; COHORT ANALYSIS; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMAGE GUIDED RADIOTHERAPY; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PARAAORTIC LYMPH NODE; PERITONEAL CAVITY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

CERVICAL CANCER; CHEMOTHERAPY; CISPLATIN; DISTANT METASTASIS; PROGNOSTIC FACTORS; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84899632509     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.004     Document Type: Article

References (43)

1. C. La Vecchia, C. Bosetti, F. Lucchini, P. Bertuccio, E. Negri, and P. Boyle et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975 Ann Oncol 21 2010 1323 1360
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
3. C. Vale Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
4. J. Green, J. Kirwan, J. Tierney, C. Vale, P. Symonds, and L. Fresco et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 4 2005 CD002225
5. R. Potter, J. Dimopoulos, P. Georg, S. Lang, C. Waldhausl, and N. Wachter-Gerstner et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155
6. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magne DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery Radiother Oncol 93 2009 316 321
7. K. Narayan, S. van Dyk, D. Bernshaw, C. Rajasooriyar, and S. Kondalsamy-Chennakesavan Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival Int J Radiat Oncol Biol Phys 74 2009 1529 1535
8. C. Chargari, N. Magne, I. Dumas, T. Messai, L. Vicenzi, and N. Gillion et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 74 2009 133 139
9. L.T. Tan, C.E. Coles, C. Hart, and E. Tait Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience Clin Oncol 21 2009 175 182
10. S. Beriwal, N. Kannan, H. Kim, C. Houser, R. Mogus, and P. Sukumvanich et al. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results Clin Oncol 23 2011 685 690
11. U. Mahantshetty, N. Khanna, J. Swamidas, R. Engineer, M.H. Thakur, and N.H. Merchant et al. Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix Radiother Oncol 102 2012 130 134
12. R. Potter, P. Georg, J.C. Dimopoulos, M. Grimm, D. Berger, and N. Nesvacil et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer Radiother Oncol 100 2011 116 123
13. J.C. Lindegaard, L. Fokdal, S.K. Nielsen, J. Juul-Christensen, and K. Tanderup MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective Acta Oncol 52 2013 1510 1519
14. C. Haie-Meder, R. Potter, E. Van Limbergen, E. Briot, M. De Brabandere, and J. Dimopoulos et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245
15. R. Potter, C. Haie-Meder, E. Van Limbergen, I. Barillot, M. De Brabandere, and J. Dimopoulos et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77
16. J.C. Dimopoulos, C. Kirisits, P. Petric, P. Georg, S. Lang, and D. Berger et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results Int J Radiat Oncol Biol Phys 66 2006 83 90
17. C. Kirisits, R. Potter, S. Lang, J. Dimopoulos, N. Wachter-Gerstner, and D. Georg Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 901 911
18. P. Trnkova, R. Potter, D. Baltas, A. Karabis, E. Fidarova, and J. Dimopoulos et al. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame Radiother Oncol 93 2009 331 340
19. J.C. Dimopoulos, V. De Vos, D. Berger, P. Petric, I. Dumas, and C. Kirisits et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations Radiother Oncol 91 2009 166 172
20. T.P. Hellebust, C. Kirisits, D. Berger, J. Perez-Calatayud, M. De Brabandere, and A. De Leeuw et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy Radiother Oncol 96 2010 153 160
21. M.P. Schmid, B. Mansmann, M. Federico, J.C. Dimopoulous, P. Georg, and E. Fidarova et al. Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study Strahlenther Onkol 189 2013 238 244
22. H.M. Keys, B.N. Bundy, F.B. Stehman, L.I. Muderspach, W.E. Chafe, and C.L. Suggs III et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161
23. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R.J. Stock, B.J. Monk, and J.S. Berek et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613
24. R. Pearcey, M. Brundage, P. Drouin, J. Jeffrey, D. Johnston, and H. Lukka et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972
25. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
26. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
27. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Jr. et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348
28. E.K. Nugent, A.S. Case, J.T. Hoff, I. Zighelboim, L.L. DeWitt, and K. Trinkhaus et al. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors Gynecol Oncol 116 2010 438 441
29. H. Fagundes, C.A. Perez, P.W. Grigsby, and M.A. Lockett Distant metastases after irradiation alone in carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 24 1992 197 204
30. H. Sakurai, N. Mitsuhashi, M. Takahashi, T. Akimoto, H. Muramatsu, and H. Ishikawa et al. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis Int J Radiat Oncol Biol Phys 50 2001 1136 1144
31. T.K. Park, J.Y. Kwon, S.W. Kim, S.H. Kim, S.N. Kim, and G.E. Kim Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma Int J Clin Oncol 9 2004 120 124
32. M.P. Schmid, C. Kirisits, N. Nesvacil, J.C. Dimopoulos, D. Berger, and R. Potter Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis Radiother Oncol 100 2011 468 472
33. S. Polterauer, C. Grimm, G. Hofstetter, N. Concin, C. Natter, and A. Sturdza et al. Nomogram prediction for overall survival of patients diagnosed with cervical cancer Br J Cancer 107 2012 918 924
34. S. Polterauer, Q. Zhou, C. Grimm, V. Seebacher, A. Reinthaller, and G. Hofstetter et al. External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer Gynecol Oncol 125 2012 526 530
35. S.H. Shim, S.W. Lee, J.Y. Park, Y.S. Kim, D.Y. Kim, and J.H. Kim et al. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy Gynecol Oncol 128 2013
36. M.P. Schmid, E. Fidarova, R. Potter, P. Petric, V. Bauer, and V. Woehs et al. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy Acta Oncol 52 2013 1384 1390
37. N.A. Mayr, W.T. Yuh, D. Jajoura, J.Z. Wang, S.S. Lo, and J.F. Montebello et al. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer Cancer 116 2010 903 912
38. J.M. Kirwan, P. Symonds, J.A. Green, J. Tierney, M. Collingwood, and C.J. Williams A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer Radiother Oncol 68 2003 217 226
39. P.J. Eifel Chemoradiotherapy in the treatment of cervical cancer Semin Radiat Oncol 16 2006 177 185
40. A. Duenas-Gonzalez, J.J. Zarba, F. Patel, J.C. Alcedo, S. Beslija, and L. Casanova et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 29 2011 1678 1685
41. A. Duenas-Gonzalez, M. Orlando, Y. Zhou, M. Quinlivan, and H. Barraclough Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial Gynecol Oncol 126 2012 334 340
42. Group ANZGO. www.anzgog.org.au/clinicaltrials/
43. UK CR. www.cancerresearchuk.org/cancer-help/trials/a-trial-of- chemotherapy-before-chemoradiation-for-cervical-cancer-interlace